LYFT Inc vs TransMedics Group Inc — how do they compare? LYFT Inc trades at $17.35 (market cap $6.64B), while TransMedics Group Inc trades at $89.4 (market cap $3.10B). The key difference: LYFT Inc is far larger — about 2.1× TransMedics Group Inc's market cap. Which is the better fit depends on your goals.
| LYFT | TMDX | |
|---|---|---|
Market Cap | $6.64B | $3.10B |
Sector | Industrials | Technology |
52-Week High | $24.57 | $150.42 |
52-Week Low | $12.65 | $61.99 |
Enterprise Value | $6.11B | $3.49B |
Signals from Pluang's Aura AI — not financial advice
Lyft trades at $17.26, down 1.15% today, with strong technical momentum showing bullish moving averages but overbought RSI signals. The company demonstrates remarkable fundamental improvement with 2025 revenue reaching $6.32B and net income surging to $2.84B, achieving a 45% profit margin. Recent Q2 2026 results showed revenue growth of 16.1% with record active riders exceeding 30 million, though earnings slightly missed estimates amid higher costs.
Lyft presents a compelling turnaround story with accelerating profitability and market share gains against Uber, supported by expanding robotaxi partnerships and international growth. However, elevated valuation multiples, competitive pressures, and ongoing legal scrutiny create headwinds. With analyst consensus at $19.17 representing 11% upside potential, the stock offers growth exposure but requires monitoring of execution risks and expense management.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →